Victory Capital Management Inc. Sells 627,080 Shares of ICU Medical, Inc. (NASDAQ:ICUI) (2024)

Victory Capital Management Inc. lowered its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 99.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,592 shares of the medical instruments supplier's stock after selling 627,080 shares during the period. Victory Capital Management Inc.'s holdings in ICU Medical were worth $458,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in ICUI. CWM LLC boosted its position in shares of ICU Medical by 341.2% during the fourth quarter. CWM LLC now owns 578 shares of the medical instruments supplier's stock valued at $58,000 after purchasing an additional 447 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of ICU Medical during the 4th quarter valued at $106,000. Private Trust Co. NA grew its position in shares of ICU Medical by 273.8% in the 4th quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier's stock worth $120,000 after buying an additional 879 shares during the period. Dark Forest Capital Management LP bought a new position in shares of ICU Medical in the 3rd quarter worth about $383,000. Finally, PAX Financial Group LLC purchased a new position in ICU Medical during the 3rd quarter valued at about $445,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Price Performance

NASDAQ ICUI opened at $101.68 on Friday. ICU Medical, Inc. has a 12 month low of $78.28 and a 12 month high of $196.57. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. The stock's fifty day moving average price is $100.94 and its 200-day moving average price is $97.41.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.39. The business had revenue of $587.86 million during the quarter, compared to analyst estimates of $564.77 million. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. On average, sell-side analysts expect that ICU Medical, Inc. will post 3.5 earnings per share for the current year.

Analyst Ratings Changes

Separately, KeyCorp upped their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the stock an "overweight" rating in a report on Wednesday, February 28th.

View Our Latest Stock Report on ICUI

Insider Activity at ICU Medical

In other ICU Medical news, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the sale, the vice president now owns 13,980 shares of the company's stock, valued at approximately $1,373,814.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the company's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $107.19, for a total transaction of $1,458,105.57. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Daniel Woolson sold 791 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the sale, the vice president now owns 13,980 shares of the company's stock, valued at $1,373,814.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 26,562 shares of company stock valued at $2,788,117. 6.70% of the stock is owned by corporate insiders.

About ICU Medical

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Featured Articles

• Five stocks we like better than ICU Medical
• High Dividend REITs: Are They an Ideal Way to Diversify?
• NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
• What is a Dividend King?
• These 2 Retail Traders Favorites are Nearing Major Breakouts
• What Is WallStreetBets and What Stocks Are They Targeting?
• Snowflake is Melting… Up, With a Double-Digit Upside Potential

Should you invest $1,000 in ICU Medical right now?

Before you consider ICU Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.

While ICU Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here